Gilead files COVID-19 drug remdesivir with FDA
pharmaphorum
AUGUST 10, 2020
It also includes the phase 3 randomised, placebo-controlled study of Veklury conducted by the National Institute of Allergy and Infectious Diseases (NIAID). The filing with the FDA follows approval by several regulators across the world, including in the European Union and Japan.
99 
Let's personalize your content